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Negotiations are underway for a new treaty for the conservation and sustainable use of
biodiversity of areas beyond national jurisdiction under the United Nations Convention
on the Law of the Sea. Points of contention in the negotiation concern marine genetic
resources and questions of monetary and/or non-monetary benefit sharing arising from
their use. Tracing the origin of marine genetic resources used in scientific research,
development and commercialization may offer the evidence needed to prove they came
from areas beyond national jurisdiction and that benefit sharing is owed. Traceability is
complex and multidisciplinary: involving legal, scientific and informatics considerations.
We look at different traceability approaches within national jurisdictions and how these
might provide lessons for the proposed treaty, using one of the few case studies
available to trace the commercial development of a marine genetic resource from areas
beyond national jurisdiction. We discuss this case study in relation to existing legal
frameworks including the Nagoya Protocol and other systems based on open sharing
of information and materials, including existing scientific practice. We conclude that
a well-designed traceability system tailored to the unique geographical, political and
jurisdictional characteristics of areas beyond national jurisdiction could lead to more
equitable outcomes for the sharing of benefits from the use of marine genetic resources.
Our key recommendations are that any traceability mechanism needs to be light touch,
integrated with existing systems such as bioinformatics databases and not impose
additional burdens on scientific users. Systems should be designed to improve scientific
knowledge of ocean biodiversity to allow better conservation measures to be developed.
If treaty negotiators engage commercial sectors to find workable policy solutions for the
draft treaty that promote greater transparency and data sharing from these sectors,
there may be a greater chance for traceability mechanisms to support benefit sharing.
Keywords: marine genetic resources, biodiversity beyond national jurisdiction, traceabilily, benefit sharing,
INSDC, open access
INTRODUCTION
Countries are negotiating a new treaty framework for the conservation and sustainable use of
marine biological diversity in areas beyond national jurisdiction (the BBNJ Agreement). Key areas
of debate in the treaty negotiations are: (1) how to regulate the collection and use of these marine
genetic resources (MGRs) that are not within the sovereign control of any country; (2) whether to
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require monetary as well as non-monetary benefits from their
use and if so; (3) how to share any benefits with other
countries, particularly developing countries who may have
limited technological capabilities to undertake this work (UN,
2019). Being able to point to evidence that a final product (e.g.,
a pharmaceutical or cosmetic) incorporates MGRs of ABNJ is
a key step for establishing that benefit sharing is owed from
the use of the original MGR. Although traceability mechanisms
are essential for establishing this connection and have been
explored in the context of genetic resource access and benefit
sharing (ABS) (Rohden et al., 2020), there is relatively little
research about how they may work in practice for the BBNJ
Agreement (see Humphries et al., 2020). Understanding what
‘traceability’ means varies between international ABS frameworks
and national laws. Using a case study of AbyssineTM, a cosmetic
product incorporating products derived from an MGR of ABNJ,
this paper aims to explore the practical operation of four key
traceability approaches and offers insights into how they may
work in the context of the BBNJ agreement.
The BBNJ Agreement proposes to address implementation
and governance gaps in the United Nations Convention on the
Law of the Sea (UNCLOS) concerning the conservation and
sustainable use of BBNJ (UN, 2012). The UN’s mandate is to
conduct four negotiating sessions for parties to agree on the
framework for four key elements concerning biodiversity – (1)
marine genetic resources (MGRs), including questions on the
sharing of benefits; (2) area-based management tools, including
marine protected areas; (3) environmental impact assessments;
and (4) capacity-building and the transfer of marine technology.
The November 2019 Draft Text includes provisions on access
and benefit sharing (ABS) of MGRs and traditional knowledge
associated with MGRs (UN, 2019)1. Section “BBNJ Proposed
Approach to Traceability in the Draft Text” outlines the current
proposed approach to traceability in the Draft Text.
During text negotiations, there has been little agreement
between countries about how to practically achieve traceability in
the BBNJ context. In the closing remarks of the third negotiating
session on the Draft Text in 2019, the Facilitator of the MGR
element outlined the differing country positions about whether
a traceability system is even desirable or feasible,
With regard to monitoring, generally, further discussions could
clarify how to balance the need for transparency in the
utilization of marine genetic resources of areas beyond national
jurisdiction with the need to avoid creating disincentives for
marine scientific research. Two divergent perspectives were
noticeable. One perspective emphasized the need for a robust
track-and-trace mechanism and consequently offered proposals
on who would be in charge of monitoring, the activities that
would be subject to monitoring, and how monitoring would be
carried out, including whether it would be through the clearing-
house mechanism, a scientific and technical body, an obligatory
notification system or a combination of those mechanisms.
Another perspective questioned the feasibility and desirability of
a monitoring mechanism that would include the use of identifiers,
notifications by databases, repositories and gene banks, and the
1Exploration of BBNJ Agreement provisions on traditional knowledge is beyond
the scope of this paper: see Mulalap et al. (2020) and Vierros et al. (2020).
submission of periodic status reports by proponents of marine
scientific research in areas beyond national jurisdiction (UN,
2019, p. 7).
Various traceability mechanisms have been proposed in
the treaty discussion to date, for example ‘track and trace.’
Conceptually it is helpful to visualize ‘track and trace’ methods
of traceability as akin to a parcel tracking system that records
the movements of a parcel at every point along the chain
of custody (Figure 1). In the context of BBNJ, this would
require reporting obligations and monitoring infrastructure
(e.g., identifiers, reports) to link subsequent uses and benefit
sharing back to the original collection of potentially very large
numbers of MGRs from areas beyond national jurisdiction
covering over 60% of the planet’s oceans (Humphries et al.,
2020). The ‘track and trace’ approach to ABS is outlined in
sections “Traceability Infrastructure Under CBD and Nagoya
Protocol” and “Track and Trace Options.” Other traceability
mechanisms are more akin to an automobile recall system
where it is not necessary to track the location of a car at
every moment (Humphries et al., 2020; Figure 1). In this case,
traceability is only triggered by an event (e.g., an engine problem)
at which time the software will piece together the ownership
details through connected databases (e.g., car registration
systems). MGR traceability options using this approach are
outlined in sections “Multilateral (Contractual) Traceability
Options” and “End-Product/End-User Traceability Options.”
Section “Existing Open-Access Traceability Options” highlights
existing open access systems and section “Combined Traceability
approaches” outlines traceability options using a combination of
traceability approaches.
Identifiers are an essential component of traceability,
which allow this connectivity between databases. For
identifiers to be valid, i.e., provide stable links (in science
generally referred to as ‘unique’ or ‘persistent’), they need
to meet certain criteria: resolvability, persistence, authority
and uniqueness (Guralnick et al., 2015). Digital Object
Identifiers (DOIs) for example fulfill these requirements.
Such identifiers are in widespread usage in biology, such as
globally unique identifiers or GUIDS (which meet the above
criteria), allocated to individual specimen records (reviewed
in Rabone et al., 2019). In contrast, current identifiers in
legal contexts are unlikely to meet these requirements or
provide stable links between systems (see section “Track and
Trace Options”).
When considering the scope of what is to be traced, there
is little agreement in the November 2019 Draft Text about
whether information associated with genetic resources should
be included in the governance and traceability arrangements
(UN, 2019, p. 6). BBNJ physical materials and information are
different entities, but intrinsically linked, given that information
originates from a sample, and the scientific value of a sample
equates to its associated data. In terms of physical sample,
a marine organism collected from an ABNJ may contain
biochemicals that can be used in generating a commercial
product or process, such as a novel pharmaceutical, or an
enzyme that can be used in an industrial process. In some
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FIGURE 1 | ‘Track and trace’ showing tracing throughout the chain of custody versus tracing origin from the end product/user (simplified example). Adapted from
Humphries et al. (2020). The images are from the Noun Project.
cases, it is the associated information generated from a sample
that is utilized for commercial applications, rather than the
physical sample itself. The use of sequence data from MGR
samples (DNA/RNA sequences and possibly protein sequences:
see Houssen et al., 2020) to generate products and processes
relies heavily on available sequence information in large databases
(i.e., INSDC, the International Nucleotide Sequence Database
Collaboration). These databases contain billions of sequences
(DNA/RNA/proteins), some of which have been annotated with
experimentally confirmed functions or putative functions based
on theoretical predictions. Using sequence information is more
straightforward for the generation of proteins and enzymes
than small molecule metabolites, e.g., potential pharmaceuticals.
Inherent in the idea of traceability of MGR is the assumption
that a link between the MGR and a final product can be
made. In some cases this may be possible (and where the ‘final
product’ is not a commercial product but a scientific publication
this is generally the case) but this becomes very difficult when
it comes to derivatives (e.g., proteins/chemical compounds).
Some forums have attempted to address this to a certain extent
e.g., intellectual property (see section “End-Product/End-User
Traceability Options”) and some multilateral systems (see section
“Multilateral (Contractual) Traceability Options”). However, the
scope of what is actually being traced is a fundamental policy
question that is missing from the ILBI discussion about how
to implement monitoring in practice. To simplify the analysis
of traceability mechanisms that relate to information associated
with genetic resources, this paper will consider the implications
for nucleotide sequence data (NSD) as a subset of information
comprised of DNA and RNA sequence data and annotations
(Houssen et al., 2020).
There is limited data showing the actual value and volume
of commercial products that incorporate MGRs of ABNJ
(Broggiato et al., 2018). On the one hand this may indicate
traceability tools are necessary to link MGR origins with benefit
sharing under the ILBI. On the other hand, it may raise
questions about whether a potential traceability mechanism is
commensurate with the scale of activity or even necessary.
This paper explores the feasibility and practical considerations
of traceability options using one of the few documented
examples of MGRs collected from ABNJ being incorporated
into a cosmetic product for commercial sale – the case of
Alteromonas macleodii subsp. fijiensis biovar deepsane (the
‘Deepsane’ strain).
There are many reported uses of MGRs in cosmetics and other
personal care products (Martins et al., 2014). Most of these are
derived from organisms collected within national jurisdiction,
but one, marketed as the face cream ‘AbyssineTM’ contains
materials derived from organisms collected in ABNJ. A French
Cruise owned and conducted by L’Institut Français de Recherche
pour l’Exploitation de la Mer (IFREMER) in 1987 (‘Hydronaut’
cruise) collected the worm Alvinella pompejana at a depth of
2625 m from a hydrothermal vent located on the East Pacific
Rise, from which a microorganism was isolated. Researchers at
IFREMER carried out the basic research on the microorganism
(16S rRNA sequence, phylogenetic and chemical analyses) that
was found to produce an unusual exopolysaccharide, which
provides protection to a cell. The bacterium (HYD657) isolated
from the worm, later identified as Alteromonas macleodii subsp.
fijiensis biovar deepsane based on its biological characteristics
and 16S rRNA2 sequence (Cambon-Bonavita et al., 2002) and
entered this genetic sequence into the European Molecular
Biology Laboratory (EMBL) database. IFREMER holds a patent
(see Table 1) for the method of producing a low-molecular-
weight sulfated polysaccharide derivative (‘Deepsane’) from
the microorganism that could be used in cosmetics and
pharmaceuticals. Later research defined the full biological activity
of this material and determined its complete chemical structure
(Le Costaouëc et al., 2012). Commercial research was conducted
by Lanatech, which patented a skin-care application of the
material. The material was produced commercially by Lucas
Meyers, later purchased by the cosmetic ingredients company
Unipex. Cosmetics incorporating the material and marketed
under the AbyssineTM brand are promoted to soothe sensitive
skin against irritation caused by chemical, mechanical and UV-
B exposure.
Table 1 identifies the key events concerning the collection,
research, development, and commercialization that are relevant
for the traceability option analysis outlined in this article.
216S ribosomal RNA sequence, GenBank Accession: AJ319537.1.
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TABLE 1 | Information obtained from a combination of the Cruise report,1
Cambon-Bonavita et al. (2002), GenBank2.
ABNJ origin ABNJ Hydrothermal vent located on the
East Pacific Rise at 2625 m depth
12o48.56′ N, 103o56.72′ W.
Collection details During October 20 – December 7, 1987 by
researchers of L’Institut Français de Recherche
pour l’Exploitation de la Mer (IFREMER) using
the ship ‘Le Nadir’ owned by IFREMER and
registered in Toulon, France.
Purpose of collection Continuing ‘ecological, biological and
physiological studies’ (cruise report).
Port of return after
collection
Manzanillo, Mexico.
Strain of interest HYD657 Alteromonas macleodii subsp. fijiensis
biovar deepsane isolated from Polychaete
annelid Alvinella pompejana
Location and date of
duplicate sample
deposit
October 17, 1995 - Collection Nationale de
Culture de Microorganismes (Institut Pasteur,
Paris, France) as strain CNCM I-1285.
Deposit of sequence
information
June 8, 2001 by IFREMER into NCBI (US
based), Accession Number AJ319537.1 (16S
rRNA sequence for taxonomic identification).





1987-2002 (date of publication) - IFREMER
Brest and Laboratoire de Microbiologie, Station
Biologique, Roscoff, France.




A private company, Lanatech, conducted the
research on the biological activity of the
‘Deepsane’ exopolysaccharide and gave it the
commercial name ‘Abyssine R© ’. Lanatech was
part of Siricie SA, but in 2003 Atrium
Biotecnologies, part of the Unipex bought
Siricie and thus Lanatech. In 2012 Siricie and
Lucas Meyers Cosmetics merged. The current
producer of Deepsane/Abyssine is Lucas
Meyers Cosmetics and the product is used in
face creams produced by Kiehl’s (bought by
L’Oreal).
Commercial interest Low-molecular-weight sulfated polysaccharide
derivative that is of pharmaceutical or cosmetic
value or of value in tissue engineering (e.g.,





French patent 93 01687 and world patent
94/18340 in 1993 EP 0 682 713 B1 (deposit
number 94907582-4), international deposit
number PCT/FR94/00169, filed February 15,
1994; Lanatech patent EP 0987010, 1998
French Patent Application No. 0406405, filed
14 June 2004; European patent EP 1171625;
PCT/FR2005/001379, filed June 6, 2005; US
Patent 8,598,142. Inventors Senni et al. (all
French), assigned to IFREMER, France. Filed





AbyssineTM Trademark e.g., US trademark registered February 24,
2004 (no. 2816085)
1ALAYSE Anne-Marie (1987) HYDRONAUT cruise, RV Le Nadir, https://doi.org/10.
17600/87004911.
2GenBank Accession AJ319537.1.
For each of the traceability options examined in section
“Traceability Policy Options and Implications,” we briefly outline
examples of legal and policy frameworks and identify key
considerations for effective implementation of the option in the
BBNJ context using the AbyssineTM Deepsane case study. In
our analysis we do not suggest those involved in Deepsane case
acted contrary to their obligations at the time of access or use.
Instead, we analyze how traceability mechanisms could work
in future for other cases, using the facts of this case. Section
“Policy Recommendations” makes policy recommendations for
traceability options in the BBNJ context followed by a conclusion
in section “Conclusion.”
TRACEABILITY POLICY OPTIONS AND
IMPLICATIONS
BBNJ Proposed Approach to Traceability
in the Draft Text
The November 2019 Draft Text outlines proposed obligations
for access and utilization of MGRs, the sharing of benefits,
monitoring and intellectual property concerning MGRs.
Countries have not yet agreed about which body would conduct
monitoring of the utilization of MGRs of ABNJ. Proposed
obligations for collecting MGRs of ABNJ include a requirement
to provide the secretariat with information about the collection,
including geographical coordinates, and to deposit samples in
collections and data in open source platforms such as databases
and gene banks [draft article 10(2)]. Negotiating countries have
agreed there should be benefit sharing obligations (draft article
11) but disagreement remains about the modalities of benefit
sharing (UN, 2019).
Options for monitoring under draft article 13 include the
proposed BBNJ clearing house mechanism, a scientific and
technical body, an electronic notification system managed by
the BBNJ secretariat and existing international institutions.
Countries disagree about traceability infrastructure that States
Parties must incorporate in their legislative and other measures
(UN, 2019). Options in the Draft Text include assigning an
identifier to MGRs collected in ABNJ and those in ex situ and
in silico conditions3, obligations for notifying a BBNJ body when
MGRs are accessed and obligations for researchers to submit
periodic status reports and research findings to a BBNJ body.
The use of the term ‘identifier’ in the Draft Text appears to
refer to a legal identifier (used for administrative purposes),
not a unique identifier associated with a specimen (generally
used for scientific purposes) that is retrievable and persistent
(see section “Existing Open-Access Traceability Options” below).
However, the meaning and use of the term in the text is not
clear, potentially causing confusion for some delegations. The
Draft Text lacks a shared understanding of: (a) the type of
identifier it proposes; (b) the capabilities or limits of legal and
scientific identifiers; and (c) how they might interact (or not) in a
practical sense within databases and between countries’ existing
3‘In silico’ is undefined but concerns information associated with the physical
materials.
Frontiers in Marine Science | www.frontiersin.org 4 April 2021 | Volume 8 | Article 661313
fmars-08-661313 April 26, 2021 Time: 10:40 # 5
Humphries et al. Traceability of MGR in BBNJ
traceability mechanisms. A key area of disagreement in the
negotiations is whether the proposed agreement should include
intellectual property provisions (UN, 2019). Options relevant to
traceability in the Draft Text include requiring States Parties to
take domestic measures to ensure that applicants or users of
patents on inventions incorporating MGRs of ABNJ disclose the
origin of the MGRs [draft article 12(3)].
Figure 2 outlines the proposed monitoring infrastructure at
the various phases of collection and use of physical materials
and NSD. This figure illustrates that the primary burden for
monitoring is on the initial researcher and not downstream
users. In relation to the Deepsane example, under the Draft Text
approach, the initial researcher IFREMER would have ongoing
reporting obligations, an obligation to assign an identifier to
samples and information and an obligation to deposit duplicate
samples in an ex situ facility. However, it is unclear how
far these obligations would extend to IFREMER to ensure
subsequent users must also comply with these traceability
measures. Downstream users such as Lucas Meyers would have
no traceability obligations under the current proposed Draft
Text model, obligations would only potentially arise if they
patented an invention incorporating BBNJ materials (possible
disclosure of origin obligations, see Table 1). In the case of
US Patent 8,598,142, the inventors and assignees are all French
based so there appears to be no traceability obligation on the
entity that commercializes the product incorporating MGRs from
ABNJ in this case.
Traceability Infrastructure Under CBD
and Nagoya Protocol
Under the Convention on Biological Diversity (CBD) and the
Nagoya Protocol on Access to Genetic Resources and the Fair and
Equitable Sharing of Benefits Arising from Their Utilization to the
Convention on Biological Diversity (Nagoya Protocol), countries
can exercise their sovereign rights to implement a traceability
system for their genetic resources and associated knowledge that
suits their national interests. The Nagoya Protocol sets up a
minimum standard of a monitoring and compliance framework
for countries to help ensure that genetic resources utilized within
their jurisdiction have been accessed in accordance with prior
informed consent (PIC), and that mutually agreed terms (MAT)
have been established (articles 15-18). The traceability elements
primarily relate to Internationally Recognized Certificates of
Compliance (IRCC), the checkpoint mechanism, the ABS
Clearing House (ABSCH) and User Measures outlined below.
Any infrastructure developed for the ILBI would need to
account for this infrastructure to avoid duplication and ensure
consistency with national CBD approaches to traceability.
The Internationally Recognized Certificates of Compliance
(IRCC), the checkpoint mechanism and the ABSCH4 is
infrastructure designed to capture evidence of compliance with
PIC and establishment of MAT in accordance with national laws.
The IRCCs are usually in the form of an access permit5 but
4See https://absch.cbd.int/
5See https://absch.cbd.int/search/nationalRecords?schema=absPermit
they may be in another form6. IRCCs must contain certain non-
confidential information, including details of issuing authority,
the provider and user, the unique identifier of the certificate
(known as the ‘ABSCH Unique Identifier’), the subject matter
of resources covered by the certificate, confirmation that PIC
was obtained and that MAT was established and the type of use
allowed under the authorization (NP article 17). Each IRCC is
issued with an ABSCH Unique Identifier, which is attached to the
certificate and not assigned to the actual genetic resources that are
the subject of the authorization. Amendments to the records can
be tracked by adding a revision number to the ABSCH Unique
Identifier7. As at March 24, 2021, there are 2142 IRCCs recorded
on the ABSCH site, but there is little information about the
movement or physical location of the genetic resources after the
ABSCH Unique Identifier is assigned.
To assist with monitoring movements within and between
jurisdictions, Parties to the Protocol must designate one or
more checkpoints to collect or receive relevant information
(including the IRCC) on PIC, MAT, and the source and use of
genetic resources (article 17). These checkpoints may relate to
the collection or use of materials or information at any stage of
the research, development, innovation, pre-commercialization,
or commercialization phases. This has resulted in a range
of checkpoints that vary according to national law, including
intellectual property offices, pharmaceutical regulatory agencies
and public research bodies, universities and museums8. Many
countries have not yet designated checkpoints and those that
do are mainly departments, organizations and institutions that
handle the movement of physical samples and not NSD.
User Measure obligations tackle movements of materials and
knowledge across borders. The Protocol requires States Parties
to establish User Measures, namely to: (a) adopt measures
to provide for compliance with provider country PIC and
MAT requirements; (b) enforce user compliance with these
measures; and (c) cooperate with other countries to address
alleged violation of provider country measures (article 15). A user
country that waives its own right to require PIC may still be
subject to these obligations to comply with provider country
requirements (Greiber et al., 2012). These obligations are duties
to confirm that users have complied with PIC at the time of
access and not an obligation on countries to apply provider
country laws and remedies (Morgera et al., 2014). There are
very few examples of countries with User Measures embedded
in their ABS legislation (e.g., Uganda9 and Malaysia10). The
European Union’s due diligence framework essentially operates
as a User Measure, where EU Member States must ensure
that before someone can use genetic resources and traditional
6For example, India has an ABS E-filing system where upon approval of access,
instead of issuing a permit, the authority enters into an agreement with the
applicant, which serves as the equivalent of an IRCC http://absefiling.nic.in/
NBA/login/auth; Indian Government (2017) Interim National Report on the
Implementation of the Nagoya Protocol (November 2, 2017).
7https://absch.cbd.int/about/faqs
8https://absch.cbd.int/search/nationalRecords?schema=absCheckpoint
9National Environment (Access to Genetic Resources and Benefit Sharing)
Regulations 2005 (section 23).
10Access to Biological Resources and Benefit Sharing Act 2017 (sections 12 and 15).
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FIGURE 2 | November 2019 Draft Text proposed obligations in relation to proposed requirements for traceability of MGR, e.g., requirement for deposit of
samples/data in an open access repository or disclosure of origin for any patent arising from a product developed from an MGR. Arrows show
movement/requirements for MGR samples or data, dashed line shows break in traceability.
knowledge in their jurisdiction, they first need to demonstrate
they were accessed in accordance with the legislation of the
providing country11.
‘Track and Trace’ Options
The benefit of using a ‘track and trace’ approach is that it helps to
provide evidence linking the benefits from the use of a particular
resource to the original access within a country. This section
uses the Deepsane example to illustrate that unless the relevant
materials fall within scope of ABS laws and all countries along the
research and development continuum for the particular resource
have traceability infrastructure and obligations similar to those
under the Nagoya Protocol framework (section “Traceability
Infrastructure Under CBD and Nagoya Protocol” above), then
it is difficult if not impossible to ‘track and trace’ the movement
of ABNJ MGRs and associated information once they leave the
possession of the original collectors of the samples.
11European Union regulation No.511/2014 of the European Parliament and of the
Council on compliance measures for users from the Nagoya Protocol on Access to
Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their
Utilization in the Union [article 4(1)].
The Nagoya Protocol’s infrastructure theoretically helps
countries that have implemented ‘track and trace’ systems to
know where the resources/knowledge are at any given time and
how they are being used. At the national level, this may also
be assisted by reporting, change of use and transfer provisions,
which significantly vary in practice between countries. Reporting
obligations range from sending regular and multiple reports to
the government on the progress of research by users, such as
in Vietnam12, to requirements for personal record keeping such
as in Australia13. Many countries such as Zambia14 require users
to reapply for government and/or community permission when
they seek to change the use of the resources or knowledge,
such as from non-commercial to commercial research. There
are several approaches that countries take to track the transfer
12Law on Biodiversity 2008 No. 20/2008/QH12 (article 60); Decree No.
59/2017/ND-CP on the Management of Access To Genetic Resources and The
Sharing of Benefits Arising From Their Utilization article 25.
13Environment Protection and Biodiversity Conservation Regulation 2000 (Cth)
section 8A.19.
14Protection of Traditional Knowledge, Genetic Resources and Expressions of
Folklore Act 2016 [section 36(h)].
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of genetic materials to third parties or transfers of materials
out of the country. Some countries such as India15 only allow
transfers with government permission in addition to the original
access requirements. Countries such as Kenya have prescribed
material transfer agreement and reporting processes for sending
resources outside the country with strict use conditions16. Other
countries like Ethiopia require letters from international users’
home countries that they will enforce Ethiopia’s ABS (including
reporting) obligations (Mulesa and Westengen, 2020). There is
little published information about whether or how countries
with ABS laws manage the usage of identifiers to trace the
materials and/or associated information under their monitoring
frameworks within and between jurisdictions in practice.
In the case of Deepsane, France might have claimed
jurisdiction over the genetic resources because they were
collected by a French research organization on a French owned
ship. Although States have no sovereign rights of ABNJ resources
in situ, once they are landed on board a vessel, they fall within
the jurisdiction of the flag state (Humphries et al., 2020). If the
ship was registered in another jurisdiction, that State might raise
a competing claim for jurisdiction over the resources. France’s
ABS law came into effect in 2016 and would not have applied
to the Deepsane collection (HYD 657). If a similar collection
were to occur today, French law excludes genetic resources
collected from areas outside its national jurisdiction, indicating
that MGRs collected from ABNJ (even those held in French
ex situ collections) are not subject to ABS and its traceability
arrangements17. However, being part of the European Union
means that users of genetic resources in France are subject
the EU’s Due Diligence system so that France must ensure
compliance with the ABS legislation of a provider Party to
the Nagoya Protocol of resources accessed after 201418. In the
Deepsane case, the resources were collected in 1987 so the EU
Due Diligence procedures again would not apply and there is no
avenue for ‘track and trace’ under this infrastructure.
There might also be competing claims to benefits from the
use of MGRs from other jurisdictions involved in the movement
of the samples and information, for example the port where
the samples were first landed after collection from ABNJ. The
question comes down to the scope of subject matter that is
captured under national laws. The CBD’s framework offers States
Parties flexibility to include within their ABS genetic resources for
which they are the country of origin or the country where they
have gained their distinctive characteristics (article 2). States have
15Biological Diversity Act in 2002 section 20(2).
16Environmental, Management and Coordination Act (Conservation of Biological
Diversity and Resources, Access to Genetic Resources and Benefit Sharing) Regulation
2006 section 18.
17‘Les ressources génétiques prélevées en dehors du territoire national et des zones
sous souveraineté ou juridiction française’ Loi n 2016-1087 du 8 aout 2016 pour
la reconquete de la biodiversite, de la nature et des paysages (1) Titer V: Accés
aux ressources genetiqués et partage juste et equitable des avantages article L412.5
(II)(1)(b). Other countries more explicitly state genetic resources from ABNJ do
not fall within their obligations e.g., Republic of Korea Act on Access to and
Utilization of Genetic Resources and Benefit-Sharing 2017 article 3.2 (unofficial
translation).
18European Union regulation No.511/2014 of the European Parliament and of the
Council on compliance measures for users from the Nagoya Protocol on Access to
Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their
Utilization in the Union article 2(4).
interpreted this in a variety of ways ranging from only including
native genetic resources within scope of their measures (e.g.,
Australia19), to including those that are simply present in their
jurisdiction, and not only those for which they are the country of
origin (e.g., Malaysia20). Some countries such as Uganda exclude
resources merely transiting through its jurisdiction21. In the
Deepsane case, the materials came from ABNJ to Mexico. Mexico
has ABS measures but not a comprehensive legally binding ABS
framework (Jefferson et al., 2018)22, which would not have applied
to the Deepsane collection in 1987. For future ABNJ collections,
whether ABS laws and ‘track and trace’ requirements apply to
transit jurisdictions, it may come down to whether the samples
are deemed to have ‘landed’ in the port country (or simply
remained on the vessel before returning home) and whether
they were in scope and accessed, used or transferred within the
meaning of the relevant ABS law of the port country.
Another jurisdiction along the chain of custody may be ex
situ facilities to which duplicate samples are sent. For example,
in the Deepsane case, a duplicate sample was sent in 1995 to
a facility in France for the purposes of satisfying patentability
requirements23 (Table 1). There may have been other samples
(not on the public record) sent to facilities in other countries that
might claim jurisdiction over them. Whether ex situ materials
are captured by ABS laws varies considerably between countries.
Some laws do not apply to ex situ resources in private facilities on
private land, while others do (e.g., Australia24). As French ABS
obligations do not appear to apply in the Deepsane case (see
above), there would be no legal obligation for subsequent users
to make public the movement of the samples to other facilities
around the world. When the resource is subsequently developed
in a country where it does fall within scope, then ABS obligations
may be triggered.
Where MGRs of ABNJ are captured under national ABS
laws and traceability mechanism, there are several infrastructure
challenges for maintaining evidence of the chain of custody
of MGRs of ABNJ through a ‘track and trace’ system similar
to that under the Nagoya Protocol’s infrastructure. Challenges
for physical materials include the reliance on users to update
the government about the use and movement of the resources,
when sometimes it is more economically viable to pay a fine for
failure to report. The international checkpoint system is designed
to catch unauthorized movements and uses but the system is
currently ad hoc with many gaps for undetected movements.
As regular information updates to the ABSCH depend on the
19Environment Protection and Biodiversity Conservation Regulation 2000 (Cth)
regulation 8A.03(1).
20Access to Biological Resources and Benefit Sharing Act 2017 section 5(1).
21National Environment (Access to Genetic Resources and Benefit Sharing)
Regulations 2005 article 4.
22E.g., National Strategy on Biodiversity (“ENBioMex”) 2016–2030 and a range of
national laws that might apply to research and species collections; see Jefferson
et al. (2018).
23Under the terms of the Budapest Treaty on the International Recognition of
the Deposit of Microorganisms for the Purposes of Patent Procedure https://www.
wipo.int/treaties/en/registration/budapest/
24Australia’s Commonwealth legislation Environment Protection and Biodiversity
Conservation Regulation 2000 (Cth) does not apply to private facilities whereas
Australia’s Northern Territory legislation does – Biological Resources Act 2006
(NT).
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goodwill or priorities of Parties to the Nagoya Protocol, often
the information about resource/knowledge uses and movements
and IRCCs is out of date or unavailable. User Measures under
the Nagoya Protocol framework only ensure that MAT have
been established and do not cover compliance with the terms or
content of a benefit sharing agreement to ensure that the share of
the benefits from the use of the materials or knowledge with the
provider is fair and equitable (Young and Tvedt, 2017). However,
the Protocol obliges all parties ‘to ensure that an opportunity to
seek recourse is available under their legal system, consistent with
applicable jurisdictional requirements, in cases of disputes arising
from mutually agreed terms’ [article 18(2)].
These challenges are magnified in the case of information
associated with MGRs. It is difficult to prove the origin
and provider of the information for the purposes of sharing
the benefits of the information’s use, particularly when the
information is used separately from the physical materials
and entered into an open-access database system (see section
“Existing Open-Access Traceability Options”). A CBD fact-
finding study in 2020 found that the only system where it is
practically possible to link an accession number of an NSD entry
to an access permit for the purposes of traceability is the ABSCH
Unique Identifier and link generated by an IRCC published on
the ABS Clearing House website (Rohden et al., 2020). Whereas
it will be possible to have a link from the metadata of the NSD
to the IRCC, the reverse may be more difficult. This is because
numbers of sequences (NSD) from a given genetic resource may
increase and linking these from the IRCC to the metadata of
the NSD will require constant updates to the IRCC. The CBD
study authors could not find an example of a linkage between
an IRCC and NSD entry and suggest the reason is the relative
novelty of the system. Tracing categories of information that are
broader than NSD such as contextual or ecological information
is beyond current technical capabilities for ‘track and trace’ and
have been excluded from the working definition of DSI (Digital
Sequence Information) by the AHTEG (Scholz et al., 2020; CBD
AHTEG report, 2020).
For this kind of ‘track and trace’ system to work in
BBNJ, due diligence evidencing compliance with ABS measures
and an update to the ABSCH Unique Identifier would be
required under national laws at every step (from collection
to final product) by the next user in every jurisdiction they
move through. Blockchain is attracting more attention as a
potential platform for recording objects, providers, users, and
ABS terms and conditions across national jurisdictions (Scholz
et al., 2020), for example through the use of smart contracts.
These contracts may take many forms but are generally a
‘computerized program between two or more parties, whose
conditions are defined in advance and stored in the blockchain,
and which can be automatically executed or enforced, without
the need for a third party’ (Carron and Botteron, 2019 p. 106).
The provider country however must have the technological
capacity to interact with the blockchain infrastructure, such
as creating, accessing, and approving smart contracts as a
basis for linking subsequent users to the original terms and
conditions of access (Scholz et al., 2020). Blockchain technology
could enable ‘track and trace’ approaches but could equally
be used for other traceability approaches outlined below.
If BBNJ negotiators or implementers consider blockchain as
a tool for MGR regulation, they might weigh the benefits
of traceability with the energy intensive requirements of
blockchain and its appropriateness for an environmental treaty
(Mignon, 2019; Leape et al., 2020). Scholz et al. (2020) have
also pointed out that major upfront investment would be
required for such technology development, which is difficult
to justify given existing traceability of NSD through the
INSDC infrastructure; and potential issues futureproofing for a
rapidly evolving technology. As a general point, maintenance
of both databases (e.g., INDSC and biodiversity databases25)
and physical collections have substantial (long-term) cost
implications (Rabone et al., 2019; Collins et al., 2020; Rohden
et al., 2020), which should be considered in the development
of any potential traceability system. The cost of developing a
new, stand-alone global traceability system should be balanced
against the more likely successful and more cost-effective
approach of building on, and improving, current scientific
collections and databases.
If BBNJ negotiators are considering extending the CBD’s ‘track
and trace’ model to MGRs collected within ABNJ, then the
infrastructure and processes would need to be compatible with
those within national jurisdiction for the reasons outlined above.
Figure 3 illustrates using the Deepsane case that while there may
be evidence of movement of samples and information from the
time of collection, there is no legal means for tracking and tracing
the materials back to BBNJ (e.g., to the BBNJ Clearing House
Mechanism). This is because firstly French ABS law (including its
monitoring and due diligence obligations) would not apply and
there is no obligation to trace movement of the materials from
the initial researchers to subsequent users such as Lucas Meyers
and other organizations that developed the compound into the
AbyssineTM product, apparently also in France. Secondly, under
the Draft Text proposed approach (see Figure 1) the use of
collected samples in ex situ conditions such as those in the
Collection Nationale de Culture de Microorganismes (France)
would be ‘open,’ resulting in a break in the chain of custody –
a chain on which the ‘track and trace’ approach depends.
Multilateral (Contractual) Traceability
Options
While the Nagoya Protocol’s traceability infrastructure largely
relates to tracking whether PIC has been obtained and MAT
have been established in accordance with national law (but
not whether a user has complied with the terms of the
agreement, see section “Traceability Infrastructure Under CBD
and Nagoya Protocol”), contractual mechanisms can accompany
the movement of materials and associated information and
knowledge across jurisdictions and be used for traceability
purposes. This section identifies how standardized material
transfer agreements (MTAs) (including data transfer agreements)
25Key biodiversity databases include GBIF (Global Biodiversity Information
Facility), www.gbif.org; the Ocean Biodiversity Information System OBIS, obis.org;
and Global Genome Biodiversity Facility, GGBN, www.ggbn.org (Droege et al.,
2014).
Frontiers in Marine Science | www.frontiersin.org 8 April 2021 | Volume 8 | Article 661313
fmars-08-661313 April 26, 2021 Time: 10:40 # 9
Humphries et al. Traceability of MGR in BBNJ
FIGURE 3 | Traceability in practice including the commercialization phase using the Deepsane/Abyssine example (not shown - patents were also filed in 1998 by
Lanatech, subsequently acquired by Lucas Meyers). Arrows show movement of data, dashed line a break in track and trace, and plain line is possible back-track of
information.
and other contractual mechanisms attach terms and conditions to
the transfer of genetic resources/information and the role these
may play in ABS multilateral traceability mechanisms.
MTAs have the potential to put the burden of compliance
with ABS obligations on end users of the biological resources
and/or knowledge. This is because contracts can include clauses
that manage the conditions of subsequent uses or transfers of
the resources/knowledge to third parties, if allowed under the
contract (Young and Tvedt, 2017). MTAs of ex situ collections of
genetic resources are increasingly incorporating ABS obligations
as part of their terms and conditions26. Some MTAs require the
recipient to exercise due diligence to ascertain that the materials
and information have been accessed and used in accordance with
PIC and MAT requirements27. The MTAs can include specific
benefit sharing obligations and clear consequences if the recipient
breaches these obligations (Von Kries et al., 2013). Standardized
26E.g., clause 7 of European Culture Collection’s Organization Material Transfer
Agreement 2009, ‘If the RECIPIENT desires to use the MATERIAL or
MODIFICATIONS for COMMERCIAL PURPOSE(S), it is the responsibility of
the RECIPIENT, in advance of such use, to negotiate in good faith the terms
of any benefit sharing with the appropriate authority in the country of origin
of the MATERIAL, as indicated by the COLLECTION’s documentation.’ https:
//www.eccosite.org
27E.g., MTAs from Belgian Co-ordinated Collections of Microorganisms; available
at: http://bccm.belspo.be/services/mta
agreements are common in the biotechnology sector and create
legal certainty for transfer of materials, intellectual property, and
evidence of provenance for physical materials (Rourke, 2019).
With machine readable technology, it is also possible to
incorporate contractual obligations for specific information
associated with genetic resources. For example, Scholz et al.
propose the use of a standard creative commons licence as an
option for an ABS tool (Scholz et al., 2020). This would be a
legally binding agreement requiring people who are submitting
DSI to a database to enter a standardized license identifier into
a metadata field linked to an online version of the license. Their
paper proposes four standardized licenses (to be determined at
an international level, e.g., through a Public/Private Partnership)
with different levels of information and benefit sharing. DSI
users would bear responsibility for keeping track of the licenses
associated with the DSI they are using, which would be less
onerous for a standardized license than case-by-case ABS
conditions. This builds on creative commons licenses (already in
widespread use in science for publishing research findings) and
depends on machine readable technology and interoperability
of databases28.
28Creative commons licenses cover over “1.4 billion species occurrence records
submitted by 1,612 publishing institutions” (Scholz et al., 2020, p. 27).
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Traceability approaches using Standard MTAs in combination
with other traceability infrastructure include multilateral ABS
systems for plant genetic resources for food and agriculture
and certain viruses. The International Treaty for Plant Genetic
Resources for Food and Agriculture (Plant Treaty) explained
briefly below uses a Standard Material Transfer Agreement
(SMTA) that does not require the provider to track single
accessions once they have afforded access to them [article
12(3)(b)] but instead passes obligations to update movements
onto subsequent users. The World Health Organization’s (WHO)
Pandemic Influenza Preparedness Framework for the Sharing
of Influenza Viruses and Access to Vaccines and other Benefits
(PIP Framework) explained below has a system of two SMTAs,
identifiers and other traceability mechanisms that trace the
movement of H5N1 influenza viruses.
The Plant Treaty creates a multilateral system of ABS
for a specific selection of plant genetic resources used
for food and agriculture but not other purposes such as
pharmaceuticals (article 10). The purpose is to enable other
Treaty Members to access plant genetic resources for research,
breeding, conservation and training, subject to benefit sharing
arrangements intended to benefit farmers, especially those from
income poor countries, who conserve and sustainably use
the resources [article 13(3)]. The terms and conditions of
transfer must be under the SMTA [article 12(4)], which is a
bilateral contract between providers (e.g., CGIAR collections)
and recipient institutions, and not a bilateral contract with
the original provider countries. Providers of multilateral
materials have no obligation to track individual accessions
but they must provide with the material all available passport
data (Lawson et al., 2018)29 and, subject to applicable law,
any other associated available non-confidential descriptive
information (article 12(3)(b)(c) and SMTA article 5). SMTA
binds non-parties to the agreement through a clause that
requires recipients to only transfer the materials under the
terms of the SMTA through a new MTA and to notify
the Governing Body of the transfer [SMTA article 6(5)(a)].
Central to the traceability framework is the Global Information
System (GLIS) that the Governing Body set up to allow
information about plant materials to be collected, made
available and shared (article 17.1). GLIS is used as an
information hub that directs users to other databases such as
the System-Wide Information Network for Genetic Resources
(SINGER) and Genetic Resources Information Network (GRIN)
(Lawson et al., 2019).
The PIP Framework is a multilateral system for the sharing
of H5N1 and other influenza viruses with human pandemic
potential, access to vaccines and sharing other benefits (article
2) that is not dependent on ABS obligations under a treaty.
Under this system, samples, sequence data and analyses must
be shared through the Global Influenza Surveillance and
Response System (GISRS), which is an international network
of influenza laboratories that conduct virus surveillance, assess
pandemic risks and assist in preparedness measures30. This
29See Glossary of Terms.
30https://www.who.int/influenza/pip/virus_sharing/en/
framework has two SMTAs of relevance to its traceability
system: SMTA 1 is between WHO (a laboratory in the GISRS)
and the depositing country’s (WHO recognized) laboratory
which contributes the physical samples to the multilateral
system; and SMTA 2 is between WHO and pharmaceutical
companies that want to access the sample for various purposes
(article 5.4.2). Transfers to subsequent users must be under
the same terms and conditions as those provided in the
SMTAs (Annex 1 article 4). The PIP Framework encourages
information sharing in publicly accessible databases and requires
WHO GISRS laboratories to submit genetic sequence data
to databases in a timely manner consistent with the SMTA
(Annex 4 principle 9)31. The PIP Framework’s Influenza Virus
Traceability Mechanism is a public access database maintained
by WHO that records the receipt and transfer of PIP biological
materials into, within and to parties outside the WHO GISRS
(Annex 4 principle 8). It enables anyone to track the transfers
of materials and the results of analyses and tests carried out
with them32.
There are challenges with applying a multilateral traceability
model similar to the Plant Treaty or PIP Framework to the BBNJ
context. These include defining the scope of ABNJ MGRs that
would fall within the multilateral system. The Plant Treaty applies
to specific crop species, while the PIP framework applies to a
specific virus strain in contrast to countless species that may be
collected from 60% of the world’s oceans (Humphries et al., 2020).
Kamau (2013); Halewood (2014) argue that the Plant Treaty
notification process is burdensome and has practical difficulties
for attempting to distinguish public domain or government-
controlled resources from those that are not. Consequently,
notifications are low. Technical and administrative burdens may
account for some of the parties’ reluctance to report (Reichman
et al., 2015). To date the process of negotiating PIP Framework
SMTA2 agreements has been lengthy and complex, resulting in
a limited number of concluded agreements, often with details
of the benefit sharing agreements unavailable to the public
(Rourke, 2019).
In the Deepsane case, we could not find information about any
MTAs used for the transfer of materials to subsequent users nor
mention of identifiers for the relevant materials. However, if they
exist, machine-readable publicly available MTAs could contribute
to the information network relevant for ABS traceability. If
these MTAs are standardized, there is a greater likelihood of
user uptake through cost and time reductions compared with
ABS negotiations on a case-by-case basis33. SMTAs may not on
their own be sufficient for effective MGR of ABNJ traceability
but they offer one means for monitoring the movement of
materials and certain information. BBNJ negotiators might
learn from the experiences of the very different PIP and Plant
Treaty (contractual) multilateral systems and may find a hybrid
31At least 6 databases contain influenza genetic sequence data: https://www.who.
int/influenza/pip/GSD_EN_3Apr2018.pdf
32https://extranet.who.int/ivtm/
33Some countries such as Uganda have standard ABS terms and conditions
embedded in their MTA requirements under national ABS laws – see National
Environment (Access to Genetic Resources and Benefit Sharing) Regulations 2005
sections 12 and 16.
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In contrast to ‘track and trace,’ emerging registration systems
relevant to genetic resource/information use offer an approach
to traceability that does not require every movement to be
traced between users and subsequent users. Instead, they require
downstream users to report products or activities at which time
certain disclosure, reporting and/or benefit sharing obligations
are triggered. The section below explores two examples of
traceability options that target the end users or end products of
genetic resource use.
The first example is an end-user registration system where
end-users rather than the initial researchers (if they are different
from the end users) engage with the traceability system. While the
Deepsane materials do not fall within scope of any end-product
traceability systems, Brazil’s ABS measures offer insight into how
this might work in practice. In 2017, Brazil changed from a
system requiring PIC and MAT at the time of access to (collection
of) its genetic resources to a registration mechanism controlling
the economic exploitation of products or reproductive materials
arising from their use (da Silva and de Oliveira, 2018). To be
granted a Certificate of Lawful Access, a user must register on the
National System for Genetic Heritage and Associated Traditional
Knowledge Management (SisGen) before a specified event such
as commercialization, intellectual property applications and
public disclosure of results (Brazil Government, 2019). Upon
Notification of a Finished Product on SisGen, parties negotiate
benefit sharing arrangements, which can be monetary (e.g.,
contribution to a fund) or non-monetary (e.g., capacity building)
(Brazil Government, 2019).
A second example is an end-product traceability system
using an Intellectual Property disclosure of origin framework
that is partially proposed as an option in the Draft Text. This
proposes obligations on parties to take measures that ensure
patent applicants that use MGRs of ABNJ disclose the origin of
the MGRs they use, and if they do not, they are ‘not approved’
(draft article 12). Patents prevent others from using a patented
product or invention without the permission of a patent holder34.
From the perspective of technology poor countries, there are
concerns of an inequitable distribution of benefits from the use
of MGRs of ABNJ to users in technologically rich countries
(Broggiato et al., 2018). The Draft Text intellectual property
provisions (see section “BBNJ Proposed Approach to Traceability
in the Draft Text” above) aim to trigger disclosure at or before the
time of commercialization of product or process inventions that
incorporate MGRs.
There are other forms of intellectual property that could
help to link end-products with ABNJ such as trademarks
and geographical indications. Geographical indications identify
a ‘good’ as originating from a particular location “where a
given quality, reputation or other characteristic of the good is
34See Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS)
article 5.
essentially attributable to its geographical origin.”35 Examples
include Champagne and Roquefort cheese in France. This form
of intellectual property provides protection (often through a
trademark or other mark) against use by a third party of a
product that does not conform to the relevant standard (e.g.,
content, production method). These are normally associated with
territories within national jurisdiction but ILBI negotiators might
consider the implications of this form of intellectual property or
a similar system for identifying origin of MGR products. On the
other hand, this type of system might lead to inequitable sharing
of benefits since an owner of a geographical indication mark
has the right to only allow other producers to use it, so long as
they comply with the relevant standards. Negotiators have used
the broad term intellectual property rights (instead of patents
which they seem to be targeting) in the Draft Text traceability
option, which may inadvertently introduce more layers of red
tape through other forms of private rights connected with
MGRs, including copyright, database protection and trademarks.
Given the emphasis on private rights inherent in intellectual
property, any system here is likely to be much less fit-for-purpose
than one based on for example current science practice, which
already emphasizes open access and publishing of data (including
collection/site information, i.e., origin of MGR).
In the Deepsane case, there appears to be a myriad of
French, European, Japanese and US patents relating to the
sample collected from ABNJ in 1987 (some examples in
Table 1), however it would require extensive investigation of
commercial-in-confidence materials to determine which of these
led to the final AbyssineTM product. Most of the patents refer
to process inventions for producing a low-molecular-weight
sulfated polysaccharide derivative from the microorganism
for a variety of applications36. Since intellectual property is
administered and enforced under national laws, determining
the extent to which the end-product incorporates MGRs of
ABNJ would require an investigation in each country where a
patent may have been claimed. In the case of Deepsane, this
is assisted through other sources such as publications (e.g.,
Cambon-Bonavita et al., 2002) and end-product marketing (e.g.,
AbyssineTM). However, the Treaty could propose a requirement
under national laws to add the specimen identifier of an MGR
from ABNJ to patent claims and then link patent databases to
patent checkpoints and/or other infrastructure that can alert the
proposed BBNJ Clearing House to its existence. What is currently
missing is an emphasis on transparency and accessibility of
patent data, where databases are numerous, but disparate and
poorly integrated.
Assuming technological developments are able to link
information, the benefits of this end-product approach to
traceability is that intellectual property systems are well
established in most countries, offering a ready-made source for
information sharing. For many years, a group of biodiversity
provider countries have been seeking amendments to the
Agreement on Trade Related Aspects of Intellectual Property
Rights (TRIPS) to require a minimum standard in national patent
35TRIPS article 22.
36E.g., US Patent 8,598,142.
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laws for disclosure of origin (WTO, 2011). While these calls have
been unsuccessful, national ABS or patent laws such as those of
Malaysia, Vietnam and India are increasingly requiring origin
disclosure when applying for or registering patents (WIPO,
2020). Despite these efforts, a 2016 study found that 90%
of patent applications do not provide information on origin
(Hammond, 2016). Without all or at least the key countries
where inventions using MGRs are patented or commercialized,
the loopholes that could be exploited by end-users targeting
countries without disclosure systems would seriously undermine
traceability. Further, there would need to be some common
standards across countries for determining to what extent a
product or process incorporates the MGRs and/or associated
information before disclosure is required (e.g., whether the
genetic trait is merely present or functional; Humphries, 2015).
Many of the current national examples only require origin to be
disclosed and not whether PIC was obtained and whether benefits
were shared with the correct provider (WIPO, 2020). Many
national laws requiring disclosure of origin for patentability
purposes only relate to materials for which they are the country of
origin, which is likely to exclude BBNJ materials. At best, tapping
into existing Intellectual Property mechanisms may only be one
ad hoc source of information for piecing together the movements
of MGRs of ABNJ.
Existing Open-Access Traceability
Options
The CBD/Nagoya Protocol do not mention open access but
the BBNJ Draft Text proposes that States Parties must take the
necessary measures “to ensure that ex situ access to [MGRs]. . .is
free and open” [draft article 10(3)]. On the other hand, it
proposes that access to MGRs in silico “is facilitated” [draft article
10(4)] without explaining what facilitation would entail. This
section explores examples of the use of open-access databases
to trace the movements of NSD under INSDC and materials
and chemical compounds in the US National Cancer Institute
Developmental Therapeutics Program (US-NCI). It concludes
with some implications of open-access traceability options for
the BBNJ agreement.
INSDC is the existing fundamental mechanism for access,
sharing and traceability of NSD. This database consortium
consists of a collaboration between GenBank (of NCBI), the
European Nucleotide Archive- ENA, and the DNA Data Bank
of Japan (DDBJ). These databases receive approximately 10
billion data requests a year (WiLDSI report, 2020)37. Open
access is embedded in the fabric of the INSDC databases and
their usage. In genetic/genomic research, publishing of data on
these databases is ubiquitous. Database accession numbers29 are
allocated to sequences upon submission and represent a unique
identifier for any sequence within the INSDC system and is
therefore key to traceability. These numbers are cited in resulting
publications; also as machine readable links in some cases (see
ABYSSLINE case study in Rabone et al., 2019). INSDC therefore
is fundamental to traceability and open access in biological
37This estimate doesn’t include downloads of the entire database (for further
information see WiLDSi Report, 2020).
research, and as such plays a critical role in supporting the
reproducibility of science. For the Deepsane example, the original
accession (16S rRNA sequence of strain HYD657) was added
to European Molecular Biology Laboratory (EMBL), accession
number AJ319537 (Cambon-Bonavita et al., 2002). The accession
numbers of the other sequences used in phylogenetic analysis
of the strain are also listed in the paper, and similarly, any
subsequent usage of the 16S rRNA sequence for phylogenetics (or
other analyses) will cite this accession number in a publication.
The EMBL entry includes the raw sequence, the publication
data, and links to the same entry in other related databases,
and records that the organism was “isolated from deep-sea
hydrothermal vent.”
Current traceability is most evident at the individual specimen
level, represented by records in biodiversity databases, such as
the Ocean Biodiversity Information System (OBIS). For MGR
collections in museums for example, specimens are allocated
a unique identifier when accessioned into a collection and a
database record is created. This identifier can then be traced
through these databases. Traceability at collections or bulk
specimen lot29 level (i.e., all specimens from a given sampling
event29) can be more challenging. For example, all collections
from a given cruise may be housed at different institutions, and
while bulk specimen lots may have entries on an institution
database they are generally not published online (Rabone
et al., 2019; Collins et al., 2020). Work is underway in the
biodiversity informatics community to try to capture the ‘gray’
data of unsorted collections, for example in publishing bulk
specimen lots on OBIS, and development of both collections-
level data descriptions (Thessen et al., 2019) and of existing
collections registries, e.g., GRSciColl (Schindel et al., 2016).
Traceability could be strengthened by further developing linkages
between INSDC and biodiversity databases, i.e., linking the
specimen record that a sequence was derived from and the
corresponding INSDC record. More fundamentally, specimens
with data published on INSDC should be archived in natural
history collections by default (Droege et al., 2019; Rabone
et al., 2019). In general, improved practices of ‘citation’ of
physical specimens/samples in the science community are needed
(Thessen et al., 2019).
In terms of sample sharing, natural history collections
have long been available to the science community (Rabone
et al., 2019), with traceability through registration/accession
numbers, referenced in associated publications (and INSDC
entries as above). Organizations such as the Global Genome
Biodiversity Network (GGBN) facilitate sharing of genomic
collections held by their partners (Droege et al., 2014). SMTAs
have also been developed for biological collections by the
science community38. For traceability of permit information, the
Global Genome Biodiversity Network (GGBN) has developed
data standards which allows for the capture of MTA, PIC,
and MAT information with the sample/collection and therefore
traceability of compliance (Droege et al., 2016). General usage
38Consortium of European Taxonomic Facilities (CETAF) have developed a SMTA
and provide best practice guidance: https://cetaf.org/services/natural-science-
collections-and-access-and-benefit-sharing
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FIGURE 4 | Existing traceability in science highlighting usage of identifiers and linkages between databases. Cruise identifier refers to the existing system of cruise
codes allocated to any deep-sea cruise, INSDC accession # refers to accession numbers allocated to sequence data submissions/records in INSDC databases
which represent a unique identifier within this system (see Glossary). Specimen identifiers refers to the unique identifiers used in biodiversity databases such as OBIS,
e.g., globally unique identifiers, or GUIDS (section “Existing Open-Access Traceability Options”). Potential traceability links between GenBank, publications and
biodiversity databases are shown as linkages and integration between some databases/publications exist but not in all cases but are not comprehensive.
and development of global data standards in biological research
such as DarwinCore for biodiversity data (Wieczorek et al.,
2012)39 and MIxS for sequence data (Yilmaz et al., 2011) has
been recently reviewed in Rabone et al. (2019). These global
standards are critical to ensure data are FAIR (findable, accessible,
interoperable, and reusable) and therefore support traceability.
Considering sample sharing for potential commercialization,
the US-NCI has a collection of ca. 100,000 plant and marine
organism extracts sourced internationally under its ‘Letter of
Collection.’40 The extracts containing mixtures of chemical
39DarwinCore is a data standard maintained by the Taxonomic Databases
Working Group (TDWG) https://dwc.tdwg.org/
40A comprehensive agreement between the source country and the US-
NCI committing it to ‘conservation of biological diversity, as well as to
compounds, but no genetic materials, are made available to
participating scientists under an MTA41, which protect the rights
of the source country, participating scientists and the US-NCI.
The open repository mechanism starts with identification of
active extracts for which materials are provided to the partner
carrying out biological activity testing, and if activity is identified,
work on the isolation of bioactives can proceed with regular
updates to the NCI. Any development is not tracked by the NCI,
policies of fair and equitable collaboration and compensation in interacting
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but the MTA requires (in addition to giving due credit to the
source country and NCI and quoting the NCI sample identifier
in publications) the participating scientists to negotiate and sign
a benefit sharing agreement with the source country before the
commercial sale of any products arising from this work. This
unique identifier must be passed on to any subsequent users.
The US-NCI open repository therefore uses a sample identifier,
together with user compliance, to trace materials from extract to
commercial product.
To apply this approach to the Deepsane example, if
commercial utilization is likely to occur, the user would be obliged
to notify the ex situ collection (or clearing house) with the
identifier of the original material leading to the product and
commit to sharing a percentage of profits with a central fund.
This approach requires user compliance by the researchers and
due diligence by downstream users. Using gatekeepers such as
national funding agencies and academic journals would ensure
that the majority of users of MGR from ABNJ could comply with
this light-touch system (see Figure 4).
Combined Traceability Approaches
Biodiversity beyond national jurisdiction policy makers may
decide to move away from the current one-size-fits all approach
to MGR traceability and instead adopt a combination of
traceability approaches and infrastructure with standard options
for a subsequent user depending on the activity or resource (see
Figure 5). Such options might include open access, contribution
to a BBNJ Fund, engagement with a purpose based multilateral
mechanism (e.g., for BBNJ conservation) and/or BBNJ Capacity
Building and Technology Transfer (e.g., ‘needs based’42) or
an end product/user model as outlined in section “End-
Product/End-User Traceability Options” above. Another option
is a subscription or tax model, requiring payments (outside the
ABS transaction) either by users accessing the resources (e.g., PIP
Framework) or an impost on contracting parties (e.g., Norway
seed sales tax) (Lawson et al., 2019). This section explores two
options that have combined approaches to traceability.
OPEN Traceability Option
The Mare Geneticum concept provides a series of building
blocks, based on good scientific practice, toward a fair and
effective regime to regulate benefit sharing of MGR from
ABNJ (Broggiato et al., 2018). Within this, a traceability system
called ‘Obligatory Prior Electronic Notification’ (OPEN) is
proposed which provides facilitated and conditional access to
MGR from ABNJ. Before a collection of MGRs is made, a
minimal dataset is recorded in the OPEN system (for instance
including information on the collector, geographical area, dates,
research aims, type of sampling) with a commitment to make
materials collected available openly in a biorepository and to
update the information in the OPEN at certain milestones
starting with provision of sample data upon return from
the collection cruise. An identifier is associated with each
sample collected and this will allow determination of its
42See closing statement of the third negotiating session section VI paragraph 10 –
UN (2019).
provenance and provide legal certainty for subsequent users,
upon change of use and at different milestones which may
include taxonomic identification, generating DNA sequences,
testing for function/activity, publication, patent application and
(potential) eventual commercial application. Benefit sharing
upon commercial income being generated is proposed to be a
fixed percentage by sector (e.g., pharmaceutical, biotechnology,
and nutrition) to help simplify negotiations. Other (non-
monetary) benefits to be shared are access to the collected
materials themselves, and to make sample and sequence
data openly available. This system requires due diligence by
subsequent users to ensure they have legal certainty by obtaining
the unique identifier, without the need for an onerous ‘track and
trace’ system as discussed in Section “Track and Trace Options.”
Tiered Approach Traceability Option
Humphries et al. (2020) propose a tiered ‘activities’ approach
to MGR governance in ABNJ as an alternative to the ‘one size
fits all’ approach currently under negotiation. In relation to
the traceability elements, the authors raise a range of options
including a user-driven and transparent web-based traceability
platform similar to the PIP Framework’s Influenza Virus
Traceability Mechanism (see section “Multilateral (Contractual)
Traceability Options”). Before undertaking activities in ABNJ,
a researcher would obtain a cruise identifier (as is common
practice), receive information on ILBI requirements and register
on a Capacity Building Database. After samples are collected
and investigated in a laboratory, the researcher would register on
an information hub. They suggest a Facilitated Information and
Sample Sharing Hub (FISSH) could offer electronic reporting of
the movement and uses of samples and data using a system of
Bulk collection identifiers. Instead of issuing unique identifiers
at collection, which may be impractical (see section “BBNJ
Proposed Approach to Traceability in the Draft Text”), the
Bulk collection identifier is associated with a given sampling
event29 and linked to all resulting collections on a given
cruise. When the samples are identified on shore, the FISSH
could link to the Bulk identifier with any unique identifiers
for specific samples and resulting sequences issued by other
repositories and databases as they move through research,
development and commercialization phases (Humphries et al.,
2020). Further investigation into this idea could include the
practicalities of assigning a Bulk Identifier for different collection
methods (e.g., trawling or single core sample), different events
(the whole cruise or a single sampling event) and different
locations (sampling within and beyond national jurisdiction on
one cruise). The authors suggest an End-User Due Diligence
Approach to benefit sharing (see section “End-Product/End-User
Traceability Options” above), including market based, research
and private sector incentives for user engagement, especially for
using information separately from the physical materials. In this
way the onus is on those doing commercial development, and
not (unnecessarily) burdensome to those doing non-commercial
biodiversity research.
Many aspects of these combined approaches are similar
to the open access in current usage in science (see Section
“Existing Open-Access Traceability Options”). A unique
Frontiers in Marine Science | www.frontiersin.org 14 April 2021 | Volume 8 | Article 661313
fmars-08-661313 April 26, 2021 Time: 10:40 # 15
Humphries et al. Traceability of MGR in BBNJ
FIGURE 5 | Combined approaches to traceability, showing potential standard options for subsequent users, such as end/product/user registration, multilateral
mechanism- purpose based (e.g., for conservation), BBNJ capacity building or benefit sharing fund (needs-based), subscription or tax models, and status quo – i.e.,
open access, no requirements. Arrow shows flow of information.
identifier accompanies a sample using a due diligence approach,
but the challenge is how to associate this with any results or
data generated from the sample. This may include taxonomic
information, nucleotide sequence data, and small molecule
derivative information, making a connected network of
information on the MGR from ABNJ. The system again relies
on due diligence by the initial and downstream users. Different
levels of requirements in the OPEN and Tiered Approach
mean different potential burdens on the users, and different
levels of data deposition either in centralized or connected
databases. It makes sense to deposit data in the relevant open-
access database such as the INSDC databases for nucleotide
sequences, taxonomic data in WoRMS, and specimen records
in biodiversity databases such as OBIS. Given existing practices
in science of publishing collections records and usage of
identifiers at various levels: cruise/sampling event/specimen
and sequence identifiers (see section “Existing Open-Access
Traceability Options”), integration with existing processes
and databases would be preferable to development of new
systems. Requirements for improved traceability, e.g., a BBNJ
bulk identifier, could be supported by the proposed BBNJ
Clearing House in the Draft Text or other body responsible for
information exchange.
The main differences between ‘track and trace’ and traceability
systems are highlighted in Figure 6 and Table 2. The complexity
and likely associated costs of full ‘track and trace’ systems means
that these are less desirable. More realistic are systems relying
on end user compliance or hybrid systems that build on current
good scientific practice and are likely to be more cost effective,
will benefit ocean science to a greater extent, and may meet with
greater user acceptance.
POLICY RECOMMENDATIONS
As with all international framework agreements, States Parties
will have the flexibility to implement their proposed BBNJ
Agreement obligations to suit their national circumstances.
However, with increasing digitization of genetic resources
in open source databases beyond the jurisdiction of any
one nation (Lawson et al., 2019) and the multi-national
characteristics of ABNJ research cruises and collaborations
(Rabone et al., 2019), policy-makers could consider designing
digital traceability arrangements for a connected world. The
key question to be addressed is whether full traceability
is feasible at all, and if so, what the costs would be of
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FIGURE 6 | Comparing track and trace and traceability options. Graphics are from the Noun Project.
an all-encompassing global traceability system. Benefits of a
truly global system, if feasible, are that material might be
traceable in multiple jurisdictions and throughout the potentially
discontinuous development pipeline. The alternative is multiple
ad hoc national systems that don’t interact well, potentially
losing sight of the development of a product as it travels
between jurisdictions and up the commercial value chain.
Below we summarize our recommendations based on the
foregoing discussions:
Recommendation 1
It is essential that any system is light touch and does not
impede marine scientific research with additional bureaucratic
burdens. Most marine scientific research is basic research,
with commercial applications far downstream. Marine scientific
research is essential to allow us to understand the basic
biology, ecology and chemistry of the oceans, permitting
the development of better conservation measures. The ideal
system will benefit marine scientific research, making it more
coordinated and connected, thus ensuring adoption/buy-in from
the scientists involved.
Recommendation 2
Any system developed should learn from, and build on,
good scientific practice so that duplication does not occur.
In the Deepsane/Abyssine example, the strain was allocated
an identifier (HYD-657) which (while not meeting current
criteria for unique identifiers, section “Existing Open-Access
Traceability Options”) was good scientific practice for the
period and crucially allowed its progress in the scientific
and patent literature to be traced over decades. Similarly,
specimens in an ex situ or data repository will generally
receive a globally unique identifier so BBNJ requirements
could adapt to existing infrastructure and scientific practice,
without duplicating requirements. Usage of persistent/unique
identifiers is a common feature in the global data ecosystem
and like usage of data standards, ensures data is FAIR
(Findable, Accessible, Interoperable, Reusable). The Draft Text or
subsequent protocols/guidelines could recognize that a model of
traceability already exists in INSDC, biodiversity databases and
scientific publications. It could seek to support these systems
as far as possible and acknowledge their centrality to biological
research. These databases are critical to the functioning biological
research community and continued open access to their data
holdings must be assured including through underwriting long-
term funding.
Recommendation 3
Traceability and reporting requirements should be placed on
the eventual end users and not the scientists. Scientists should
follow best practice guidelines for data and sample management
including recording relevant identifiers in databases/publications
and archiving of samples in natural history collections including
those where associated sequences are published (Droege et al.,
2019; Rabone et al., 2019). If the Deepsane/Abyssine example
had required benefit sharing this would be possible as the
identifier is quoted in the patents, so an end user compliance
mechanism might be feasible. This would require buy-in from
stakeholders which may be possible via market-based (e.g.,
certification), funding-based (e.g., grant incentives) or corporate
(e.g., Global Compact) incentives (Humphries et al., 2020).
Given that AbyssineTM refers to the BBNJ origin in its name,
product information and advertising materials, it is a good
example of how end-users could engage with the proposed BBNJ
frameworks if it has some form of incentive to declare the
origin of MGRs at a defined stage of research like the Brazilian
approach. The alternative may be a very complex and costly
global full ‘track and trace’ system which may not be desirable
or even feasible.
Recommendation 4
In addition to incentives (‘carrots’), enforcement measures
(‘sticks’) may be required to encourage end users to engage
with the system. Humphries et al. (2020) suggest that ‘stick’
measures might include an alert back to the proposed
ABNJ Clearing House, for example through the existing
CBD checkpoint infrastructure (see section “Traceability
Infrastructure Under CBD and Nagoya Protocol”) for products
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TABLE 2 | A summary of the compliance burden, practicality and cost/benefit proportionality for the different traceability options discussed.
Traceability option Compliance burden Practicality for tracing across
jurisdictions
Proportionality of cost v benefit
BBNJ Draft Text Prior notification of cruise deposited
with clearing house (Unique
identifier) Deposit sample metadata
with clearing house. Deposit initial
location MGR in ex situ collections
with clearing house. Deposit data
and related information in open
source platforms.
Clearing house should be globally
accessible. Not clear at present
what level identifier applies at e.g.,
cruise, collection or other Clearing
house should be globally
accessible. Clearing house should
be globally accessible. Open
source platforms are globally
accessible and apply Findable,
Accessible, Interoperable and
Reusable (FAIR) principles.




could be used to develop better
conservation measures but does
not factor in the high costs of
curation and on whom the burden
would fall. For data deposits in
open source platforms there is low
cost (data deposition according to
good scientific practice) and high
benefit for marine scientific research
through better cooperation and
coordination.
Track and trace National-level system to record
current location of material, change
of use and movements across
borders. Potentially show evidence
of compliance at each step. May be
requirement for deposit of duplicate
sample.
Hard to trace between jurisdictions
if systems have different
requirements or do not exist.
Depends on compatibility of
national systems. Dependent on
permitted international access to ex
situ collection.
High effort (and possibly cost) for
comparatively little benefit.
Materials may be traceable
between jurisdictions that have
traceability infrastructure in place.
Very high effort for initial collectors
and user, rather than downstream
(e.g., commercial) users. High cost
to maintain collections. Low benefit
if collection not globally findable
and accessible.
Material transfer agreements Develop standard material transfer
agreement. Users responsible to
keep track of materials/DSI used.
Good if globally agreed and
accessible online. Less onerous if
standardized licenses used.
Relatively low cost with potentially
high benefits. Requires user to have
good internal data management
procedures.
End user (product registration) End user reports product/activity
triggering benefit sharing
obligations.
Good if identifiers are used globally. Low cost but requires end users to
have good internal data
management procedures and
incentives to pass on identifiers to
subsequent users.
End user (patents) Disclose origin of the MGRs used in
patent.
Good if used globally. National
intellectual property systems may
have different requirements
undermining patent traceability.
Low cost but requires national
patent offices to have good internal
data management procedures and
global connectivity between
databases.
Open access Low – follow good scientific
practice to deposit data (and
samples) in global data repositories
and connected collections. Unique
identifier assigned to
data/materials.
Data/MGR in open access
databases/collections applying
FAIR principles should be globally
connected and accessible ensuring
easy traceability.
Cost currently borne by global data
repositories and ex situ collections.
No obligations financial or
otherwise for commercial sector.
Benefits are very high if all users are
able to use data/MGR to fullest
extent.
that have information (e.g., an identifier) associated with a
species linked to an ABNJ Bulk Identifier. If the Deepsane
case was to occur today, French ABS laws might not be
triggered but the ILBI could still require alerts from its
checkpoints43. For this to be workable, infrastructure between
43The Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation
(at the stage of external funding of research projects) and the Ministère de la
Transition Ecologique et Solidaire (in charge of requests for access to genetic
resources and traditional knowledge and sharing benefits from their use in France):
https://absch.cbd.int/countries/FR
the Nagoya Protocol and the ILBI need to be compatible for a
coherent system.
Recommendation 5
There is a need for increased transparency in the commercial
phase regarding movement and use of resources and data.
For the Deepsane/Abyssine example, relevant information
was available about the scientific research, but it was much
harder to get information about the commercial research
phases because information held in private databases for
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commercial objectives are not well integrated or connected.
This could be solved to a certain extent by clarifying origin
of material and information in the patent claim and labeling
on eventual products. For scientific reasons, location of
collection (with GPS coordinates) is a standard field in the
INSDC databases, although recording of these data could
be improved (reviewed in Rabone et al., 2019). The World
Intellectual Property Organization (WIPO) is moving to allow
machine readable NSD, meaning that sequences included in
patents can be automatically linked to their INSDC database
entries, and linked to origin if specified in the record44.
Such a model could allow origin of material to be specified
indirectly in patents. In addition, some information from
MTAs should be made publicly available insofar as this
does not break confidentiality. An arms-length body that
gathers anonymized information might encourage industry to
share information on the size of its business and profits
under general headings such as ‘pharmaceuticals,’ ‘enzymes,’
or ‘cosmetics’ amongst others without sharing details of the
exact products. Some information regarding origin such as
whether the MGR was obtained from an EEZ or ABNJ would
segregate the data in a useful way. The proposed arms-length
body could aggregate the data to give an estimate of the
overall size of the blue biotechnology market under these
headings and show how much is from the EEZ and how
much from ABNJ, all without industry divulging commercially
sensitive information.
Recommendation 6
There is a need to clarify the extent of the commercial
enterprise around MGR from ABNJ and how fast it is expected
to grow in the future. For instance, the Deepsane/Abyssine
example may have remained overlooked until now, but extensive
analysis is still required to fully explore the size of current
and future biotechnology based on BBNJ. Most surveys to
date have focused on healthcare products, but we need to
find hidden uses of marine biotechnology such as enzymes,
agriculture, personal care products and nutritional products.
Whereas scientific literature and patent searches may yield a
large amount of information, many fields such as cosmetics
and nutrition may not use patents to protect their products
and will remain undiscoverable. Even profits made from
particular BBNJ-derived products may be confidential and a
mechanism may need to be developed to obtain this information
without divulging commercially sensitive information. On
the question of whether it is feasible or even desirable to
develop a new traceability system, there is a need for an
independent and evidence-based assessment of the extent
of commercial benefits from MGRs of ABNJ and a cost-
benefit analysis of the potential implications of traceability
requirements for scientific progress in technology-rich and




The fourth IGC of the BBNJ process has been postponed until
August 2021. The intersessional period has given delegates and
civil society ample time to consider and informally discuss
the more complex issues in the process. We hope that our
discussion and recommendations in this paper will add to the
evidence needed to develop a workable traceability approach that
benefits marine scientific research and ocean conservation. We
have illustrated through a concrete example that a full ‘track
and trace’ system is not workable or even desirable. Evidence
from the current implementation of the Nagoya Protocol at a
national level shows that such systems are often non-existent or
incomplete and would not allow any level of traceability at an
international level.
Any additional traceability requirements imposed by the ILBI
will need to be carefully assessed with consultation and input
from marine science and bioinformatics communities and other
stakeholders and it is vital that additional administrative burdens
are minimized and any that arise are borne by commercial
end-users rather than initial researchers. Improved traceability
that builds on current good practice will benefit science by
making data and materials widely available in a consistent
and coordinated fashion. These measures could benefit the
baseline biodiversity research that is needed to develop the
most effective conservation measures in ABNJ. Our case study
shows that good scientific practice makes traceability possible
through the scientific process even though the collections were
made several decades ago. However, traceability either slows
considerably or stops when a product enters commercialization.
The commercial sector therefore needs to be engaged in finding
workable solutions for the Draft Text to be more transparent
and share vital data that will make traceability possible, following
on from current scientific practice that encourages openness.
This could include measures such as sharing of MTAs, the use
of direct or indirect measures (including incentives) to disclose
the source of MGRs in products or patents and initiatives
to gather anonymized information about the commercial use
of MGRs from ABNJ that may otherwise be commercially
sensitive. The availability of commercial data showing how many
products based on MGR from ABNJ exist or are being developed
would indicate the size and growth of the global market and
assist in assessing whether a potential traceability mechanism is
commensurate with the scale of activity. A landscape analysis of
usage of identifiers both within science and in the commercial
phase in a BBNJ context is another crucial step for an effective
traceability system.
Drawing from the Deepsane example, the seven policy
recommendations in this paper essentially urge an approach
that is a light touch, builds on existing traceability mechanisms
including proper usage of identifiers and places obligations
on end-users through incentives and transparent measures
that encourage commercial buy-in. The feasibility and
desirability of developing a traceability system should be
based on comprehensive evidence, particularly the implications
of any legal requirements on publicly funded science. Even
well-intentioned legal requirements may have unintended
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consequences. Importantly, negotiators of the ILBI have
the benefit of learning from the challenges with national
implementation of traceability under the Nagoya Protocol
framework, which cannot effectively cope with advances in
scientific practice, such as the use of digital sequence information.
A well-designed traceability system tailored to the unique
geographical, political and jurisdictional characteristics of ABNJ
could lead to more equitable outcomes for the sharing of benefits
from the use of MGRs. Ultimately it will create a greater
depth of knowledge of the oceans and biodiversity, enabling
their conservation and sustainable use by current and future
generations.
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GLOSSARY
ABNJ, Areas Beyond National Jurisdiction; ABS, Access and Benefit Sharing; ABSCH, Access and Benefit Sharing Clearing House
(the CBD clearing house mechanism); ABSCH Unique Identifier, the identifier allocated by the ABSCH Clearing House, unique
within that system; AN, Accession number (specifically for INSDC database entries): these represent a unique identifier for a record
within the INSDC system; BBNJ, Biodiversity Beyond National Jurisdiction; BBNJ Bulk Identifier, a collection level or bulk specimen
lot identifier (see ‘bulk specimen lot’ below); Bulk specimen lot, mixed and unsorted sample/specimen lots, generally containing
different species but from one sampling event for example all the organisms from a trawl are preserved and stored in one container,
for future identification/analysis; CBD, Convention on Biological Diversity; DOI, Digital object identifier; DDBJ, DNA Data Bank
of Japan; DSI, Digital Sequence Information; ENA, European Nucleotide Archive; EMBL, European Molecular Biology Laboratory;
GGBN, Global Genome Biodiversity Network; GISRS, Global Influenza Surveillance and Response System; GUID, Globally Unique
Identifier; IFREMER, L’Institut Français de Recherche pour l’Exploitation de la Mer; ILBI, International Legally Binding instrument;
IRCC, Internationally Recognized Certificates of Compliance; INSDC, International Nucleotide Sequence Database Collaboration;
MAT, Mutually Agreed Terms; MGR, Marine Genetic Resource; MTA, Material Transfer Agreement; Nagoya Protocol, Nagoya
Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization to the
Convention on Biological Diversity; NCBI, National Center for Biotechnology Information; NSD, Nucleotide Sequence Data; OBIS,
Ocean Biodiversity Information System; Passport data, information required under Plant Treaty article 12.3(c), which is ‘essentially
identifying information that allows the correct material to be properly exchanged (Lawson et al., 2018); PIC, Prior Informed Consent;
PIP, Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and other Benefits;
Plant Treaty, International Treaty for Plant Genetic Resources for Food and Agriculture; Sampling event, the collection or sampling
at a given locality and timepoint, for example a box core sample recovered from the sea floor, or a trawl recovered from the water
column would be considered a discrete sampling event; SMTA, Standard Material Transfer Agreement; TRIPS, Agreement on Trade
Related Aspects of Intellectual Property Rights; UNCLOS, United Nations Convention on the Law of the Sea; WHO, World Health
Organization; WIPO, World Intellectual Property Organization.
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